ReviewNature protocols2026
Investigation of mechanical forces during multicellular early angiogenic sprouting by three-dimensional traction force microscopy in hydrogel matrices.
Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hydrogel microneedles functioning in pathological surroundings: where soft materials overcome hard scars.Materials today. Bio · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Elucidating the mechanical regulation of angiogenesis remains a challenge owing to the complexities of measuring cellular forces in this dynamic, multicellular and three-dimensional (3D) process. Current methods for force measurements typically involve traction force microscopy (TFM) applied to single cells or monolayers on 2D substrates or to individual cells within 3D extracellular matrix (ECM)-like gels. Here we present a protocol for mimicking and imaging dynamic early angiogenic sprouting into biomimetic matrices compatible with 3D TFM and for visualizing matrix degradation. Given that reliably acquiring sufficiently large 3D TFM datasets in multicellular systems is challenging, our protocol emphasizes best practices for higher-throughput data acquisition and for accurately imaging, analyzing and interpreting cell-ECM forces using our open-source TFMLAB software. As such, this assay provides a defined and reproducible system to study cellular forces and matrix degradation during angiogenesis in response to perturbations of cell-intrinsic signaling and mixed cell populations, as well as ECM cues. We further provide protocols for immunofluorescence analysis of angiogenic sprouts formed within the matrices and their retrieval from the hydrogel for downstream sequencing. Depending on the number of samples, sample preparation can take between 2 h and 4 h followed by a 15-17 h overnight wait time for angiogenic invasion. The 3D TFM data acquisition can take 2-6 h, while downstream processing of samples can take either 1 h (endothelial cell isolation) or up to 5 d (immunofluorescence). Notably, this workflow demands minimal prior expertise in programming, biophysics or molecular biology.
Indexed as
Identifiers
41578092What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.